疫苗接种相关肩部损伤(SIRVA)
疫苗接种相关肩部损伤(SIRVA)是接种疫苗后24至48小时内出现的持续性肩部功能障碍,表现为肩痛、僵硬和无力。文献报道病例近期快速增加,尤其成人,可能与COVID-19和流感大规模接种有关。病理生理未明,推测与注射位置过高致疫苗进入三角肌下滑囊或关节囊周围组织引发炎症有关;神经传导检查通常正常,影像可显示异常但均为无症状人群常见表现;英国基于注射部位错误的医疗法律索赔不太可能达到认定责任的法律门槛。
要点
- SIRVA于接种后24至48小时内起病,表现为肩痛、僵硬和无力组合。
- 文献报道病例近期快速增加,尤其成人,可能与COVID-19和流感大规模接种有关。
- 神经传导检查通常正常,影像发现的异常在一般无症状人群中亦常见。
核心结论
- SIRVA是接种疫苗后24至48小时内开始的持续性肩部功能障碍,症状包括肩痛、僵硬和无力组合。
研究设计与样本
- 原文未报告研究设计、样本量或检索范围。
主要发现
- 文献中SIRVA报告病例近期快速增加,尤其成人,可能与COVID-19和流感大规模接种有关。
- 病理生理不确定,有观点认为疫苗注入三角肌下滑囊或其他关节囊周围组织导致炎性关节囊过程。
- 有假说认为与疫苗注射部位「过高」相关,并易感SIRVA。
- 神经传导检查通常正常,进一步影像可显示三角肌深部积液、肩袖肌腱病和撕裂或肩峰下三角肌下滑囊炎。
- 上述影像表现均为一般无症状人群中的常见发现。
临床怎么用
- 原文未据此给出推荐。
局限性
- 病理生理不确定。
- 影像所见的三角肌深部积液、肩袖肌腱病和撕裂或肩峰下三角肌下滑囊炎均为一般无症状人群中的常见发现。
- 英国基于注射部位错误的医疗法律索赔不太可能达到认定责任的法律门槛。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Shoulder injury related to vaccine administration (SIRVA) is a prolonged episode of shoulder dysfunction that commences within 24 to 48 hours of a vaccination. Symptoms include a combination of shoulder pain, stiffness, and weakness. There has been a recent rapid increase in reported cases of SIRVA within the literature, particularly in adults, and is likely related to the mass vaccination programmes associated with COVID-19 and influenza. The pathophysiology is not certain, but placement of the vaccination in the subdeltoid bursa or other pericapsular tissue has been suggested to result in an inflammatory capsular process. It has been hypothesized that this is associated with a vaccine injection site that is "too high" and predisposes to the development of SIRVA. Nerve conduction studies are routinely normal, but further imaging can reveal deep-deltoid collections, rotator cuff tendinopathy and tears, or subacromial subdeltoid bursitis. However, all of these are common findings within a general asymptomatic population. Medicolegal claims in the UK, based on an incorrect injection site, are unlikely to meet the legal threshold to determine liability.
引用
- Jenkins PJ, Duckworth AD. SIRVA: Shoulder injury related to vaccine administration. Bone Joint J. 2023. PMID: 37524358. doi:10.1302/0301-620X.105B8.BJJ-2023-0435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。